Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methionine phosphinate is a synthetic small molecule analog of the amino acid methionine in which the carboxylic acid group is replaced by a phosphinic acid moiety. It has been studied primarily as an experimental compound and is not approved for clinical use. Methionine phosphinate acts as an inhibitor of methionine aminopeptidase, an enzyme responsible for removing the N-terminal methionine from nascent proteins during protein synthesis[1][6]. By inhibiting this enzyme, it can interfere with protein maturation and function. The compound has been used in biochemical research to probe enzymatic mechanisms and potential therapeutic targets related to protein processing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methionine phosphinate.